Mark Martinez

As VP of Commercial at Intelliseq, I’m proud to lead our go-to-market strategy and commercial partnerships as we bring next-generation genomic interpretation tools to clinical and biopharma innovators around the world. Intelliseq’s pipelines empower personalized medicine by making complex genomic data both actionable and accessible—turning sequencing insights into real-world clinical value.With a background in cellular and molecular biology and a proven track record in biotech sales and strategy, I thrive at the intersection of science and commercialization. I’m passionate about translating cutting-edge technology into scalable solutions that drive better outcomes—for patients, researchers, and healthcare systems alike.Prior to Intelliseq, I led business development efforts at Inventia Life Science, a leader in 3D bioprinting, and managed high-performing teams at EpigenDx, where we consistently exceeded sales targets through data-driven, customer-centric approaches.If you're working in precision medicine, clinical genomics, or biotech innovation and want to explore partnership or collaboration, let's connect.